{"id":770768,"title":"NACI statement on recommendations on pneumococcal vaccines, CCDR 49(2/3) - Canada.ca","sourceCode":"phac","sourceName":"Public Health Agency of Canada","language":"en","captureDate":"2026-03-06","captureTimestamp":"2026-03-06T02:59:08.454000+00:00","jobId":7,"originalUrl":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2023-49/issue-2-3-february-march-2023/naci-statement-public-health-reccomendations-pneumococcal-vaccines.html","snippet":"NACI statement on public health recommendations on pneumococcal vaccines Download this article as a PDF Published by: The Public Health Agency of Canada Issue: Volume 49-2/3, February/March 2023: Early Warning in Public Health Date published: February/March 2023 ISSN: 1481-8531…","rawSnapshotUrl":"/api/snapshots/raw/770768","browseUrl":"https://replay.healtharchive.ca/job-7/20260306025908/https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2023-49/issue-2-3-february-march-2023/naci-statement-public-health-reccomendations-pneumococcal-vaccines.html#ha_snapshot=770768","mimeType":"text/html","statusCode":200,"captureBackend":"playwright_warc","captureFidelity":"fallback"}